ARK Invest focuses solely on disruptive innovation and offers investment solutions to investors seeking long-term growth in the public markets.
1Brigham and Women's Hospital, Boston, MA, 2Harvard Medical School, 3Dana Farber Cancer Institute, Boston, MA Disclosures: Peter Sorger: Advisory Board, RareCyteScientific; Stock, RareCyteScientific, Glencoe Inc. Background: Craniopharyngiomas are epithelial neoplasms of the sellar/parasellar region ...
Array-based comparative genomic hybridization (aCGH) was performed using the stock 1x1M Agilent SurePrint G3 Human CGH Microarray chip to identify tumor-specific genomic copy number changes in FFPE clinical samples (Craig JM., et al., PLoS One. 2012; 7(6):e38881). Results: aCGH revealed ...
1311 p16 Expression and Prognostic Value in Laryngeal Squamous Cell Carcinomas – A Large Cohort Study from Chinese Patients J Leidy, K Chen, T Stockl, W Ye, Q Wu, J Liang, B Woda, Z Jiang. University of Massachusetts Medical School, Worcester, MA; State Key Laboratory of Oncology in ...